Shirodaria, C., Antoniades, C., Lee, J., Jackson, C., Francis, J., Robson, M., Ratnatunga, C., Pillai, R., Neubauer, S., & Channon, K. (2016). No additional improvement in vascular function with high dose vs. low dose folic acid in coronary artery disease - Implications for HOPE-2. 114(18), 578–579.

Shirodaria, C., et al. No Additional Improvement in Vascular Function with High Dose vs. Low Dose Folic Acid in Coronary Artery Disease - Implications for HOPE-2. no. 18, 2016, pp. 578–79.

Shirodaria, C, C Antoniades, J Lee, C Jackson, J Francis, M Robson, C Ratnatunga, R Pillai, S Neubauer, and K Channon. 2016. “No Additional Improvement in Vascular Function with High Dose vs. Low Dose Folic Acid in Coronary Artery Disease - Implications for HOPE-2.” In , 114:578–79.